Dear Editor,
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Perspectives on the pharmacological management of alcohol use disorder: are the approved medications effective?.Eur J Intern Med. 2022; (Online May 18)https://doi.org/10.1016/j.ejim.2022.05.016
- Nalmefene in alcohol misuse: junk evaluation by the European medicines agency.BMJ. 2014; 348: g2017
- Risks and benefits of nalmefene in the treatment of adult alcohol dependence: a systematic literature review and meta-analysis of published and unpublished double-blind randomized controlled trials.PLOS Med. 2015; 12e1001924
- Comparing nalmefene and naltrexone in alcohol dependence: is there a spin?.Pharmacopsychiatry. 2016; 49: 260-261
- Evaluation in alcohol use disorders - insights from the nalmefene experience.BMC Med. 2016; 14: 119
- Vibration of effects from diverse inclusion/exclusion criteria and analytical choices: 9216 different ways to perform an indirect comparison meta-analysis.BMC Med. 2019; 17: 174
- Baclofen and alcohol use disorders: breakthrough or great white Elephant?.Alcohol Alcohol. 2020; 55: 49-50
- Restoring the Bacloville trial: efficacy and harms.Addiction. 2020; 115: 2184-2186
- Risk of hospitalisation and death related to baclofen for alcohol use disorders: comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.Pharmacoepidemiol Drug Saf. 2018; 27: 1239-1248
Haute Autorité de Santé. BACLOCUR (baclofène). 11 December 2019. Available at https://www.has-sante.fr/jcms/p_3124375/fr/baclocur-baclofene Accessed 9 July 2022.
- Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis.BMJ Open. 2019; 9e024886
- The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses.World Psychiatry. 2022; 21: 133-145
- Unhelpful prescribing in alcohol use disorder: risk and averting risk.Alcohol Alcohol. 2019; 54: 1-4
Article info
Publication history
Published online: August 01, 2022
Accepted:
July 29,
2022
Received in revised form:
July 9,
2022
Received:
June 30,
2022
Identification
Copyright
© 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
